dbo:abstract |
Fenpiverinium is an anticholinergic and antispasmodic compound; it is marketed as a combination drug with pitofenone hydrochloride and either nimesulide or metamizole in Eastern Europe and India to treat smooth muscle spasms and pain. The combination with metamizole was removed from the market in Lithuania for safety reasons in 2000 and a boxed warning against use by children and adolescents was added in Serbia in 2005. In 2016 India banned marketing of the combination with nimesulide along with 344 other combination drugs; the order was overturned in December and appealed by the Government in January 2017. (en) |
dbo:casNumber |
258329-46-3 |
dbo:fdaUniiCode |
KP2L8LC73B |
dbo:pubchem |
71490 |
dbo:thumbnail |
wiki-commons:Special:FilePath/Fenpiverinium.png?width=300 |
dbo:wikiPageID |
19926252 (xsd:integer) |
dbo:wikiPageLength |
4504 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1060033496 (xsd:integer) |
dbo:wikiPageWikiLink |
dbc:Butyramides dbr:Antispasmodic dbc:Piperidines dbr:Anticholinergic dbr:Combination_drug dbc:Muscarinic_antagonists dbc:Quaternary_ammonium_compounds dbr:Nimesulide dbr:Pitofenone dbr:Metamizole |
dbp:atcPrefix |
A03 (en) |
dbp:atcSuffix |
AB21 (en) |
dbp:c |
22 (xsd:integer) |
dbp:casNumber |
258329 (xsd:integer) |
dbp:charge |
+ (en) |
dbp:chemspiderid |
64566 (xsd:integer) |
dbp:h |
29 (xsd:integer) |
dbp:iupacName |
1 (xsd:integer) |
dbp:n |
2 (xsd:integer) |
dbp:o |
1 (xsd:integer) |
dbp:pubchem |
71490 (xsd:integer) |
dbp:smiles |
C[N+]1CCCCN (en) |
dbp:stdinchi |
1 (xsd:integer) |
dbp:stdinchikey |
QDIYJDPBMZUZEH-UHFFFAOYSA-O (en) |
dbp:unii |
KP2L8LC73B (en) |
dbp:verifiedrevid |
443757813 (xsd:integer) |
dbp:watchedfields |
changed (en) |
dbp:wikiPageUsesTemplate |
dbt:Gastrointestinal-drug-stub dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Drugbankcite dbt:Fdacite dbt:Drugs_for_functional_gastrointestinal_disorders dbt:Muscarinic_acetylcholine_receptor_modulators |
dcterms:subject |
dbc:Butyramides dbc:Piperidines dbc:Muscarinic_antagonists dbc:Quaternary_ammonium_compounds |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatMolecularFormulas yago:WikicatMuscarinicAntagonists yago:Abstraction100002137 yago:Adversary109773245 yago:CausalAgent100007347 yago:Communication100033020 yago:Formula106816935 yago:LivingThing100004258 yago:Message106598915 yago:MolecularFormula106817173 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo dbo:Drug yago:Statement106722453 yago:Whole100003553 umbel-rc:DrugProduct |
rdfs:comment |
Fenpiverinium is an anticholinergic and antispasmodic compound; it is marketed as a combination drug with pitofenone hydrochloride and either nimesulide or metamizole in Eastern Europe and India to treat smooth muscle spasms and pain. (en) |
rdfs:label |
Fenpiverinium (en) |
owl:sameAs |
freebase:Fenpiverinium yago-res:Fenpiverinium wikidata:Fenpiverinium dbpedia-sh:Fenpiverinium dbpedia-sr:Fenpiverinium dbpedia-vi:Fenpiverinium https://global.dbpedia.org/id/4k1mD |
prov:wasDerivedFrom |
wikipedia-en:Fenpiverinium?oldid=1060033496&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/Fenpiverinium.png |
foaf:isPrimaryTopicOf |
wikipedia-en:Fenpiverinium |
is dbo:wikiPageRedirects of |
dbr:C22H29N2O+ dbr:C22H29N2O dbr:ATC_code_A03AB21 dbr:ATCvet_code_QA03AB21 |
is dbo:wikiPageWikiLink of |
dbr:C22H29N2O+ dbr:Algifen dbr:C22H29N2O dbr:ATC_code_A03AB21 dbr:ATCvet_code_QA03AB21 dbr:ATC_code_A03 dbr:Pitofenone |
is foaf:primaryTopic of |
wikipedia-en:Fenpiverinium |